Start
Now! Create on line tests, quizzes, surveys and exams in minutes!
|
|
|
|
   
|
||||||
|
|
2007-07-17 News Release
Chemicals group partners with biotech company Ciba Specialty Chemicals collaborates with biotechnology company to develop novel functional surface effects from renewable raw materials.
The goal of Ciba Specialty Chemicals and BRAIN AG of Zwingenberg, Germany, one of Europe’s leading industrial biotech companies, is to identify, characterize and synthesize biomolecules that lend new functionality to surfaces such as plastics, paper, coatings and home and personal care products. BRAIN brings to the collaboration a large library of microorganisms, broad expertise in white biotechnology and proprietary test systems, while Ciba contributes cutting-edge application and process development as well as global marketing capability. The resulting biomaterials will produce novel and improved surface effects, such as bioprotection, enhanced printability in polymers and moisture resistance in a variety of materials. “Biotechnology presents new opportunities for Ciba to bring innovative functional surface effects to diverse markets, and this collaboration reflects our commitment to investing in this key future technology,” says Martin Riediker, Chief Technology Officer at Ciba. “In working to develop biofunctional materials from renewable resources, we also strengthen our commitment to sustainable manufacturing. We look forward to expanding our partnership with BRAIN, with its proven record of leveraging biotechnology for industrial applications, in this exciting area of research.”
“BRAIN complements Ciba’s application knowledge of functional surfaces with our broad, long-standing expertise in identifying and developing innovative biomolecules,” says Jürgen Eck, Chief Technology Officer at BRAIN AG. “Our EvoSolution technology platform makes it possible to identify candidate molecules, create production strains and conduct fermentation as well as substance and process optimization. We are glad to support Ciba in strengthening its position as a leader in creating and marketing innovative effects.” Ciba and BRAIN have previously collaborated on using designer microorganisms to develop new biotechnological processes for the sustainable production of existing specialty products. The expanded partnership and exclusive collaboration will focus on creating new biomaterials with novel functional surface effects. Ciba will hold exclusive distribution rights for any resulting products within the field of collaboration. BRAIN, founded in 1993, is a research and development company which discovers
and develops novel bioactive natural compounds and proprietary enzymes
for its partners and customers in the chemical and pharmaceutical as well
as the food and cosmetics industries. In a unique approach to the discovery
and production of new biological compounds and biocatalysts, the company
harnesses creative solutions from nature’s untapped biodiversity.
Its success is built on its proprietary BioArchive comprising millions
of genes, proteins and metabolic pathways from microbial isolates and
metagenome libraries. Today, BRAIN has developed into one of Europe’s
leading industrial biotech companies. Chemicals Engineer Jobs - Post Employment Opportunity!
Click here to view more news headlines. E-mail this page to a friend
|
|
 News / Resources - Chemicals group realigns Rhein Chemie unit - Certification, Training and Courses from The American Management Association - Small Quantity Specailist - Plastics, Metals, Tool Steel and ... - Looking for a Study Program? - All this Months News - Changing Jobs? View a Wide Range of Real Estate Nationwide - 2007 Ad-Aware release - anti-spyware protection - Golf Equipment Manufacturer -Buy Direct and Save! Copyright - Unless
otherwise stated all
contents of this web site are © 1998/2007 JOBWERX.COM.
|
|
